Montgomery, Robert A. https://orcid.org/0000-0003-2728-4552
Stern, Jeffrey M. https://orcid.org/0000-0001-5588-0357
Fathi, Farshid https://orcid.org/0000-0002-0280-7612
Suek, Nathan
Kim, Jacqueline I. https://orcid.org/0000-0001-8165-525X
Khalil, Karen
Vermette, Benjamin https://orcid.org/0000-0003-4292-1281
Tatapudi, Vasishta S.
Mattoo, Aprajita
Skolnik, Edward Y.
Jaffe, Ian S. https://orcid.org/0000-0002-7309-308X
Aljabban, Imad
Eitan, Tal https://orcid.org/0000-0002-0811-6871
Bisen, Shivani https://orcid.org/0000-0002-2585-0154
Weldon, Elaina P.
Goutaudier, Valentin
Morgand, Erwan
Mezine, Fariza
Giarraputo, Alessia
Boudhabhay, Idris
Bruneval, Patrick https://orcid.org/0000-0002-2350-2914
Sannier, Aurelie
Breen, Kevin
Saad, Yasmeen S. https://orcid.org/0000-0001-6612-7985
Muntnich, Constanza Bay
Williams, Simon H.
Zhang, Weimin https://orcid.org/0000-0002-8836-1438
Kagermazova, Larisa https://orcid.org/0009-0004-7494-284X
Schmauch, Eloi
Goparaju, Chandra
Dieter, Rebecca
Lawson, Nikki
Dandro, Amy
Fazio-Kroll, Ana Laura
Burdorf, Lars
Ayares, David
Lorber, Marc
Segev, Dorry
Ali, Nicole
Goldfarb, David S. https://orcid.org/0000-0002-9215-1273
Costa, Victoria
Hilbert, Timothy
Mehta, Sapna A.
Herati, Ramin S. https://orcid.org/0000-0003-2613-4050
Pass, Harvey I.
Wu, Ming
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
Keating, Brendan https://orcid.org/0000-0002-3320-3723
Mangiola, Massimo https://orcid.org/0000-0002-5406-4005
Sommer, Philip M.
Loupy, Alexandre
Griesemer, Adam https://orcid.org/0000-0003-4894-2024
Sykes, Megan https://orcid.org/0000-0002-4947-4376
Article History
Received: 21 July 2024
Accepted: 3 November 2025
First Online: 13 November 2025
Change Date: 12 February 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-026-10252-w
Competing interests
: J.B. is a founder and director of CDI Labs Inc., a founder of and consultant to Opentrons LabWorks/Neochromosome Inc., and serves or served on the scientific advisory board of CZ Biohub New York LLC, Logomix Inc., Modern Meadow Inc., Rome Therapeutics Inc., Tessera Therapeutics Inc. and the Wyss Institute. R.A.M. has received research funds from Lung Biotechnology, a wholly owned subsidiary of United Therapeutics Corporation, PBC and ChoironeX. R.A.M. has served on the advisory boards for eGenesis and Recombinetics. M.S. has received research funds from Lung Biotechnology and from ChoironeX,